GLP-1 Providers Serving New York (2026)

Browse by medication

Already know which molecule you want? These two lists split the New York providers by drug.

Rules and Context in New York

New York has a strong telehealth framework supporting GLP-1 prescribing. New York Medicaid covers GLP-1s for both diabetes and obesity with prior authorization.

• •New York's adult obesity rate is 28.9%
• •New York Medicaid covers GLP-1s with prior authorization
• •NYC is the largest telehealth GLP-1 market in the Northeast

A further 293 sellers in the register publish no state list at all, so we cannot say whether they reach New York. Not disclosing is itself worth knowing, and it is recorded on each of their entries in the register.

Where Demand Concentrates in New York

A telehealth service will ship to any address in New York. The searches, and the clinics, cluster in these metros:

In person instead: the New York GLP-1 clinic directory →

Getting It Covered in New York

A type 2 diabetes diagnosis is what usually unlocks a GLP-1 in New York: Ozempic and Mounjaro are covered widely on that basis. Ask for Wegovy or Zepbound on an obesity indication alone and you are into prior authorization, or a flat no. When the brand is out of reach, compounded semaglutide through telehealth is the cheaper road, running near $229/mo here.

Obesity Rates in New York

CDC figures put 28.9% of adults in New York at a BMI of 30 or higher, which ranks the state #41 of 50. Telehealth has widened access to semaglutide and tirzepatide considerably since, and it is now the route most New York residents take to get supervised treatment without leaving home.

Before settling on a medication, read the clinical-trial results sitting behind each one, then our rankings for semaglutide and tirzepatide providers. What is coming next is tracked in the next-generation GLP-1 pipeline.

Frequently Asked Questions